Enrosite
Loading...Enrosite Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
For use in animals only. The use of this product in cats may result in Retinal Toxicity. Keep out of reach of children.
Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposure. Individuals with a history of hypersensitivity to quinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight.
For customer service, to obtain a copy of the Material Safety Data Sheet (MSDS) or to report adverse reactions call 1-866-591-5777.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Enrosite™ (brand of enrofloxacin) Injectable Solution is indicated for the management of diseases in dogs associated with bacteria susceptible to enrofloxacin.
History
There is currently no drug history available for this drug.
Other Information
Enrofloxacin is a synthetic chemotherapeutic agent from the class of the quinolone carboxylic acid derivatives. It has antibacterial activity against a broad spectrum of Gram negative and Gram positive bacteria (See Tables I and II). Each mL of injectable solution contains: enrofloxacin 22.7 mg, n-butyl alcohol 30 mg, potassium hydroxide for pH adjustment and water for injection, q.s.
CHEMICAL NOMENCLATURE AND STRUCTURAL FORMULA:
1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid.
Sources
Enrosite Manufacturers
-
Mwi/vetone
![Enrosite (Enrofloxacin) Injection, Solution [Mwi/vetone]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Enrosite | Mwi/vetone
Enrosite Injection for Dogs may be used as the initial dose at 2.5 mg/kg. It should be administered intramuscularly (IM) as a single dose, followed by initiation of enrofloxacin tablet therapy.
Enrosite Injection for Dogs may be administered as follows:
*The initial Enrosite Injection for Dogs administration should be followed 12 hours later by initiation of enrofloxacin tablet therapy.
Weight Of Animal Enrosite™ Injection for Dogs*
2.5 mg/kg 9.1 kg (20 lb) 1.00 mL 27.2 kg (60 lb) 3.00 mLThe lower limit of the dose range was based on efficacy studies in dogs where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology studies were used to establish the upper limit of the dose range and treatment duration.
Login To Your Free Account